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Necrotic areas showed the largest reduction in baseline MBF. Dyssyner-
gic viable regions showed a reduced resting MBF, but maintained a residual
perfusion reserve in response to inotropic stimulation. Thus, Nisoldipine se-
lectively improved basal perfusion in dysynergic viable myocardium.
'p < 0.05vs Normal, @p < 0.05vs Viable, 'p < 005 vo relative Basal. 'p < 0.05 vo Basal
before Nisoldipine
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After infarction, regional dysfunction can occur in still viable myocardial re-
gions because of the presence of baseline hypoperfusion. Recent evidence
suggests that these areas may maintain a residual perfusion reserve. Aim of
this study was to evaluate whether oral Nisoldipine can increase regional my-
ocardial myocardial blood flow (MBF) in dyssynergic but viable myocardium
after myocardial infarction. To this purpose, 15 patients with isolated left
anterior descending coronary (LAD) stenosis were studied 1 month after
first myocardial infarction. Patients underwent F18-deoxiglucose imaging,
while MBF was measured, using positron emission tomography and 13N-
Ammonia, at baseline and following dobutamine (10 Ilcglkg/min over 5 min-
utes, DOB). MBF measurements were repeated 24 hours later after Nisoldip-
ine (10 mg bid). Among atotal of 102 LAD related regions, 23 showed normal
wall motion at 2D-echo and normal metabolic activity INormal), 58 showed
wall motion abnormality and preserved deoxiglucose uptake (Viable), while
21 dyssynergic regions were necrotic (Necrotic). MBF data (mllmmf1 00 g)
were as follows:
flow inhomogeneity (CD/control flow ratio: 0.58 ± 0.10 vs 0.81 ± 0.22, re-
spectively, p ± 0.02). Despite so different coronary anatomy (one vessel oc-
cluded the other normal), a linear, direct correlation was observed between
flow reserve of CD and remote regions (r = 0.83, P < 0.01). Thus, despite
resting hypoperfusion, CD maintains a residual perfusion reserve that can
be almo~t fUlly utilized during moderate increases in oxygen consumption.
A global microvascular disorder affects the adaptation to chronic coronary
occlusion.
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Gene transfer to the vascular wall utilizing locally-delivered recombinant ade-
noviral vectors has shown promise as a novel technique for therapeutic as
well as experimental modulation of vascular wall gene expression. Infusion
of such vectors using porous balloon catheters WBC) has previously been
demonstrated to result in transduction of extravascular cells at the deliv-
ery site, as well as substantial systemic transduction as a consequence
of release of vector into the circulation. Introduction of a vascular-directed
promoter into the adenoviral vector should thus contribute to targeting the
expression of genes to the vascular wall, while reducing peri-vascular and
systemic expression. In order to test the feasibility of utilizing the vascu-
lar smooth muscle a-actin (SMA) promoter to confer tissue specificity upon
a recombinant adenoviral vector, we constructed an adenovirus (AvLacZ5)
employing a 1.1 kilobase region of the murine SMA promoter to direct the
expression of the nuclear-targeted beta-galactosidase (lacZ) gene and eval-
uated gene transduction by this vector, in comparison with a vector differing
only by the presence of the RSV-LTR promoter. Several cell types were used
as targets, including bovine aortic smooth muscle cells (BASMCl. human
pulmonary epithelial carcinoma cells (A549 cells), and transformed human
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This study was designed to prospectively compare myocardial perfusion
imaging with rubidium-82 (B2Rb) by positron emission tomography (PET) to
technetium-99m - methoxyisobutyl isonitrile (MIBI) by single photon emis-
sion computed tomography (SPECT). Detection of inducible ischemia and
prior infarction was assessed in 53 patients (pts) with known coronary artery
disease (CAD) who had undergone quantitative coronary angiography. To
assign independently myocardial viability both techniques were compared
to resting, glucose loaded myocardial uptake of fluorine-18 fluorodeoxyglu-
cose (FOG) PET in a subgroup of 27 pts. with left ventricular wall motion ab-
normalities. Intravenous dipyridamole vasodilatation (0.7 mglkg) was used
as myocardial stress modality, with B2Rb and MIBI being injected simulta-
neously under identical hemodynamic conditions. SPECT and PET results
were scored in a 13 segment model of the left ventricle as normal. inducible
ischemia, infarction or infarction with adjacent ischemia. There were con-
cordant findings in 48 out of 53 analysed pts. (91 %). However, in 5 pts.
(9%) MIBI-SPECT showed fixed perfusion defects but ischemia by B2Rb-PET
and evidence of viable myocardium with FOG-PET. whereas there was no
segment with infarction in B2Rb-PET and ischemia in SPECT. We conclude
that MIBI-SPECT detects less inducible ischemia but more fixed perfusion
defects compared to B2Rb-PET in the same patient population. Sensitivity
of stresslrest B2 Rb-PET in detection of 2:70% stenosed vessel was 33/33
(100%) in LAD territory respectively 31/32 (97%) in LCx/RCA territory with
specificity of 93%. MIBI SPECT sensitivity in the same group was 29/33
(88%) for LAD and 31/32 (97%) for LCx/RCA territory with specificity of 90%
in LAD territory respectively 71 % in LCx/RCA. These data strongly suggest
that MIBI-SPECT underestimates the presence of ischemic and still viable
myocardium in comparison to B2Rb_ and FOG-PET. In contrast myocardial vi-
ability as assessed by B2 Rb- and FOG-PET correlated well. Thus stress/rest
B2Rb-PET holds promise for reliable assessment of reversible ischemia and
myocardial Viability.
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Myocardial blood flow (MBF) regulation in collateral dependent myocardium
(CD) of patients with coronary artery disease has not been fUlly elucidated.
To this purpose, 19 patients with stable angina, no previous myocardial in-
farction and isolated occlusion of the left anterior descending (n = 14) or
left circumflex (n = 5) coronary artery were evaluated. MBF measurements
were obtained off-therapy, using dynamic positron emission tomography and
nitrogen-13 Ammonia, at baseline, during atrial pacing tachycardia and after
i.v. dipyridamole (0.56 mg/l:g over 4 min). MBF in CD and remote regions
were compared with MBF values Obtained in 13 normal subjects. At rest.
MBF was similar in CD and in the remote myocardium (0.61 ± 0.11 vs 0.63
± 0.17 mllmin/gl. both values were lower than normal (1.00 ± 0.2 ml/min/g,
p < 0.01). During pacing MBF increased to 0.84 ± 0.25 and 1.11 ± 0.39
ml/min/g in CD and contralateral areas, respectively (p < 0.05 vs baseline);
both these values were lower (p < 0.01) than normal (1.86 ± 0.61 mllmin/g).
Dipyridamole induced a further increase in MBF in remote areas (1.36 ± 0.57
mllmin/g, p < 0.01 vs pacing) but not in CD (0.93 ± 0.37 mllmin/g, ns vs pac-
ing); both values were reduced (p < 0.01) with respect to normals (3.46 ±
0.78 mllmin/g). Dipyridamole MBF in CD was slightly lower in patients with
poor than in those with well developed cOllaterals (0.75 ± 0.29 vs 1.06 ±
0.38 ml/min/g, respectively, p = 0.06). however, the former showed a higher
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